Your browser doesn't support javascript.
loading
The MitoNEET Ligand NL-1 Mediates Antileukemic Activity in Drug-Resistant B-Cell Acute Lymphoblastic Leukemia.
Geldenhuys, Werner J; Nair, Rajesh R; Piktel, Debbie; Martin, Karen H; Gibson, Laura F.
Afiliação
  • Geldenhuys WJ; Department of Pharmaceutical Sciences, School of Pharmacy (W.J.G.), Department of Microbiology, Immunology and Cell Biology, School of Medicine (R.R.N., K.H.M., L.F.G.), Robert C. Byrd Health Sciences Center (W.J.G., R.R.N., D.P., K.H.M., L.F.G.), and WVU Cancer Institute (W.J.G., K.H.M., L.F.G.), W
  • Nair RR; Department of Pharmaceutical Sciences, School of Pharmacy (W.J.G.), Department of Microbiology, Immunology and Cell Biology, School of Medicine (R.R.N., K.H.M., L.F.G.), Robert C. Byrd Health Sciences Center (W.J.G., R.R.N., D.P., K.H.M., L.F.G.), and WVU Cancer Institute (W.J.G., K.H.M., L.F.G.), W
  • Piktel D; Department of Pharmaceutical Sciences, School of Pharmacy (W.J.G.), Department of Microbiology, Immunology and Cell Biology, School of Medicine (R.R.N., K.H.M., L.F.G.), Robert C. Byrd Health Sciences Center (W.J.G., R.R.N., D.P., K.H.M., L.F.G.), and WVU Cancer Institute (W.J.G., K.H.M., L.F.G.), W
  • Martin KH; Department of Pharmaceutical Sciences, School of Pharmacy (W.J.G.), Department of Microbiology, Immunology and Cell Biology, School of Medicine (R.R.N., K.H.M., L.F.G.), Robert C. Byrd Health Sciences Center (W.J.G., R.R.N., D.P., K.H.M., L.F.G.), and WVU Cancer Institute (W.J.G., K.H.M., L.F.G.), W
  • Gibson LF; Department of Pharmaceutical Sciences, School of Pharmacy (W.J.G.), Department of Microbiology, Immunology and Cell Biology, School of Medicine (R.R.N., K.H.M., L.F.G.), Robert C. Byrd Health Sciences Center (W.J.G., R.R.N., D.P., K.H.M., L.F.G.), and WVU Cancer Institute (W.J.G., K.H.M., L.F.G.), W
J Pharmacol Exp Ther ; 370(1): 25-34, 2019 07.
Article em En | MEDLINE | ID: mdl-31010844

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Proteínas Mitocondriais / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Proteínas Mitocondriais / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pharmacol Exp Ther Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos